De Pascali Alessandra Mistral, Ingletto Ludovica, Succi Arianna, Brandolini Martina, Dionisi Laura, Colosimo Claudia, Gatti Giulia, Dirani Giorgio, Zannoli Silvia, Frassineti Valeria, Silvestrini Giulia, Biagetti Carlo, Cristini Francesco, Bassi Paolo, Cricca Monica, Sambri Vittorio, Scagliarini Alessandra
Unit of Microbiology, The Greater Romagna Area Hub Laboratory, Cesena 47522, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna 40138, Italy.
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna 40138, Italy.
J Infect Public Health. 2025 Aug;18(8):102824. doi: 10.1016/j.jiph.2025.102824. Epub 2025 May 15.
Fever of Unknown Origin (FUO) is broadly defined as a fever with an unidentified cause despite a minimum set of diagnostic investigations. The variability of FUO etiologies across geographic areas, age groups, and decades makes diagnosis challenging and complicates the adoption of a standardized diagnostic approach. Global warming and changing interactions between humans, animals, and the environment are contributing to the emergence and re-emergence of zoonotic infections. Emerging Vector-Borne Disease (VBD) pathogens circulate in Northern Italy, but their prevalence and impact on febrile illnesses remain poorly understood. This study investigated FUO epidemiology, diagnosis, and treatment in three hospitals in Emilia-Romagna (northeastern Italy).
The medical records from 652 patients who were discharged with the International Classification of Diseases, Ninth Revision (ICD-9) codes "780.6 Fever of unknown origin" and "087.9 Relapsing fever, unspecified" between January 2017 and December 2023 were analysed.
Among patients discharged with FUO between 2017 and 2023, the mean age was 58 years, and 45 % older than 65 years. Comorbidities were present in 75 %, and 26 % had active cancer. A diagnostic hypothesis was present in 32 % of cases. Diagnostic tests were mainly laboratory-based; 5.9 % had confirmed infections. Antibiotics were used in 62 % of patients mostly penicillin/beta-lactamase inhibitors. FUO discharges peaked in summer.
Active hospital-based surveillance are crucial to deepen our current understanding on FUO epidemiology and possible contribution of VBD pathogens while refining the use of antibiotics in the clinical practice.
不明原因发热(FUO)被广泛定义为尽管进行了一系列最低限度的诊断性检查,但病因仍未明确的发热。FUO病因在不同地理区域、年龄组和数十年间存在差异,这使得诊断具有挑战性,并使采用标准化诊断方法变得复杂。全球变暖和人类、动物与环境之间不断变化的相互作用,促使了人畜共患感染的出现和再次出现。新兴的媒介传播疾病(VBD)病原体在意大利北部传播,但其流行情况及其对发热性疾病的影响仍知之甚少。本研究调查了意大利东北部艾米利亚 - 罗马涅地区三家医院的FUO流行病学、诊断和治疗情况。
分析了2017年1月至2023年12月期间出院的652例患者的病历,这些患者的国际疾病分类第九版(ICD - 9)编码为“780.6不明原因发热”和“087.9未特指的回归热”。
在2017年至2023年期间因FUO出院的患者中,平均年龄为58岁,45%的患者年龄超过65岁。75%的患者存在合并症,26%的患者患有活动性癌症。32%的病例存在诊断假设。诊断测试主要基于实验室检查;5.9%的患者确诊感染。62%的患者使用了抗生素,主要是青霉素/β - 内酰胺酶抑制剂。FUO出院人数在夏季达到峰值。
基于医院的主动监测对于深化我们目前对FUO流行病学的理解以及VBD病原体可能的作用至关重要,同时有助于在临床实践中优化抗生素的使用。